Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
Peptide Gels for 3D Cell Culture
Health Technologies at Strathclyde United Kingdom flag United Kingdom
Abstract ID:
Tuneable gels for cell culture scaffolding...
Contact
Participants
You
Email me a copy of this message

BACKGROUND


 


Commercial scaffolds for cell culture are widely used in drug discovery, cell biology and oncology, and form part of the $1.6B world wide cell based and screening analysis market. Historically, this has used 2D platforms but 3D cell matrices are increasingly used to provide a more accurate representation of such ‘wet environments’. We conservatively estimate that there are some 165,000 researchers actively engaged with in vitro cell culture worldwide


 


 


THE TECHNOLOGY


 


Required performance of gels for 3D Cell Culture:


 


(1) Ease of cell distribution; (2) Neutral pH; (3) Handling at 37°C (body temperature); (4) Rapid, reproducible gelation under mild conditions; (5) Good and tuneable mechanical stability (similar to that of tissue); (6) Uniformity of gel at the nano, micro and macroscopic levels; (7) Longevity in culture/in vivo; (8) Ease of biological functionalisation.


 


None of the existing commercial gel products accurately represent all of the above. Our peptide gels show significant improvement for the majority of these characteristics. In particular, they can be tailored to suit different cell types, including mesenchymal stem cells, chondrocytes, fibroblasts and hepatocytes both for 2D and 3D culture, and have mechanical properties which can be tailored to match thoseof natural tissue scaffolds.


 


KEY BENEFITS


 


Compatible with range of cell types; fully synthetic; gels are stable under biologically acceptable conditions; short peptide chains enable design flexibility; incorporation of biologically

Type of Business Relationship Sought

Gels are now available for evaluation by industry and academe.

FEATURED
Last Updated Oct 2013
Technology Type
Phase of Development EARLY STAGE
UNIVERSITY